These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HuR Affects Proliferation and Apoptosis of Chronic Lymphocytic Leukemia Cells via NF- Xiao K; Yang L; Gao X; An Y; Xie W; Jingquan G Biomed Res Int; 2020; 2020():1481572. PubMed ID: 32908868 [TBL] [Abstract][Full Text] [Related]
6. Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies. Melvold K; Giliberto M; Karlsen L; Ayuda-Durán P; Hanes R; Holien T; Enserink J; Brown JR; Tjønnfjord GE; Taskén K; Skånland SS Mol Oncol; 2022 Mar; 16(5):1153-1170. PubMed ID: 34861096 [TBL] [Abstract][Full Text] [Related]
7. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006 [TBL] [Abstract][Full Text] [Related]
8. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. McCaig AM; Cosimo E; Leach MT; Michie AM Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196 [TBL] [Abstract][Full Text] [Related]
9. TRAF1 Signaling in Human Health and Disease. Edilova MI; Abdul-Sater AA; Watts TH Front Immunol; 2018; 9():2969. PubMed ID: 30619326 [TBL] [Abstract][Full Text] [Related]
13. The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action. Chen R; Tsai J; Thompson PA; Chen Y; Xiong P; Liu C; Burrows F; Sivina M; Burger JA; Keating MJ; Wierda WG; Plunkett W Blood Cancer J; 2021 Mar; 11(3):57. PubMed ID: 33714981 [TBL] [Abstract][Full Text] [Related]
14. BCL-2 Inhibitors, Present and Future. Ryan CE; Davids MS Cancer J; 2019; 25(6):401-409. PubMed ID: 31764121 [TBL] [Abstract][Full Text] [Related]
15. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells. Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595 [TBL] [Abstract][Full Text] [Related]
16. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma. Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676 [TBL] [Abstract][Full Text] [Related]
17. Signal transduction inhibitors in chronic lymphocytic leukemia. Ma S; Rosen ST Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084 [TBL] [Abstract][Full Text] [Related]
18. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Hallaert DY; Jaspers A; van Noesel CJ; van Oers MH; Kater AP; Eldering E Blood; 2008 Dec; 112(13):5141-9. PubMed ID: 18796631 [TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218 [TBL] [Abstract][Full Text] [Related]